Chemical Compound
Pentadecanoic acid, 3-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, .mu.-lactone, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-
CAS Registry Number
114-07-8
Primary record
Pentadecanoic acid, 3-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, .mu.-lactone, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-
- 库存
- 6,973 克
- 纯度
- 99.6 %
- CAS
- 114-07-8
化合物标识与属性
- CAS
- 114-07-8
- PubChem CID
- 3255
- SMILES
- CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
- Canonical SMILES
- CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O
名称与同义词
- erythromycin
- Erythrogran
- Erythromycin A
- Erythrocin
- Erythromid
- Pantomicina
- Propiocine
- Abboticin
- Erycinum
- Ilotycin
- Dotycin
- Eryderm
- Ilocaps
- Erycin
- erythro
- Kesso-Mycin
- Taimoxin-F
- Abboticine
- Abomacetin
- Bristamycin
- Eritrocina
- Erythroguent
- Gallimycin
- Pediamycin
- Torlamicina
- Erycette
- Qidmycin
- Robimycin
- Staticin
- Stiemycin
- Eratrex
- Ermycin
- Meberyt
- Erycen
- Erygel
- Erymax
- Erypar
- Erytab
- Ethril
- Inderm
- IndermRetcin
- Retcin
- Aknin
- Emgel
- erythromycin-A
- E-Mycin
- Erythromycin B
- Theramycin Z
- Dowmycin E
- Wyamycin S
- Erythromycin D3
- Ak-Mycin
- Pfizer-E
- Erythromast 36
- Ery-Tab
- ERYC
- Erythrocin stearate
- E-Base
- T-Stat
- Erythromycin A dihydrate
- Erythromycin dihydrate
- Ethril 250
- ERYTHROMYCIN STEARATE
- Erythromycin, dihydrate
- Erythromycin-13C,d3
- Benzamycin (Salt/Mix)
- AC1L1FIQ
- Erythromycin, sodium salt
- SGI-1776 free base
- RefChem:1073650
- AC1Q2UA1
- E-mycin, Erycin, Robimysin
- A/T/S
- ETHRIL 500
- UNII-LXW024X05M
- UNII-T0O317A6OW
- Erythromycin stearate (salt)
- E- mycin, Erycin, Robimysin
- ERYTHROMYCIN A DIHYDRATE
- Erythromycin, stearate (salt)
- DTXSID90859206
- Erythromycin steraric acid salt
- Erythromycin, phosphate (salt)
- CCRIS 1504
- OE 7
- CHEMBL1671887
- component of Drixin (Salt/Mix)
- SCHEMBL15263177
- BDBM86313
- component of T-stat (Salt/Mix)
- CTK5C1089
- HSDB 4178
- CID3255
- DTXCID80196652
- Erythromycin octadecanoate (salt)
- Erythromycin stearate [BAN:JAN]
- Erythromycin octadecanoate (1:1)
- Erythromycin sodium lauryl sulfate
- ULGZDMOVFRHVEP-UHFFFAOYSA-N
- C37H67NO13
- C37H67NO13.2H2O
- Erythromycin, octadecanoate (salt)
- HMS5079F04
- NCI-C55674
- NSC55929
- EINECS 211-396-1
- AR-1H0723
- BBL028236
- MFCD00084654
- NSC-55929
- NSC_12560
- SBB057401
- STK249736
- thyl-6-oxacyclotetradecane-1,7-dione
- 114-07-8
- AKOS005423023
- Erythromycin stearate [USP:BAN:JAN]
- Octadecanoato de Eritromicina, (1:1)
- C37H67NO13.C18H36O2
- adecane-2,10-dione (non-preferred name)
- AN-22734
- C37-H67-N-O13.2H2-O
- CAS_114-07-8
- FE176617
- DB-041196
- FT-0603313
- FT-0625700
- NS00076487
- component of Benzedrex nasal spray (Salt/Mix)
- Stearic acid, compd. with erythromycin (1:1)
- C37-H67-N-O13.C18-H36-O2
- 59319-72-1
- I06-0245
- Octadecanoic acid, compd. with erythromycin (1:1)
- Sulfuric acid, sodium salt, compd. with erythromycin
- 643-22-1
- 6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
- 959119-26-7
- (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- (3S,4R,6S,7S,9S,12R,13R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
- 1025065-69-3
- 11-[4-(dimethylamino)-3-hydroxy-6-methyl(2H-3,4,5,6-tetrahydropyran-2-yl)oxy]- 5-ethyl-3,4,12-trihydroxy-9-(5-hydroxy-4-methoxy-4,6-dimethyl(2H-3,4,5,6-tetra hydropyran-2-yl)oxy)-2,4,8,10,12,14-hexame
- 4501-00-2
- 6-((4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-((5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6 dimethyl-oxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-1 oxacyclotetradecane-2,10-dione
- 6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- 6-{[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetr
- 6624-81-3
- EM
- EMU
- N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine
- Oxacyclotetradecane-2, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- PCE
- Pentadecanoic acid, 3-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, .mu.-lactone, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-
- Pentadecanoic acid,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, .mu.-lactone, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-
- WLN: T-14-VO GVTJ C2 DQ D1 EQ F1 H1 JQ J1 L1 N1 KO-BT6OTJ CQ DN1 & 1 F1 & MO-FT6OTJ B1 CQ DO1 D1